Top Markets
Coin of the day
Apimeds Pharmaceuticals US, Inc Apimeds Pharmaceuticals US, Inc

Apimeds Pharmaceuticals US, Inc

APUS
Rankning i aktier #33690
Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage... Apimeds Pharmaceuticals US, Inc. (APUS) functions as a clinical-stage biopharmaceutical firm operating within the United States. This company is dedicated to the entire lifecycle of its flagship product, Apitox – from its initial investigation and development to its production, market introduction, and sales. Apitox, a key active pharmaceutical ingredient, is specifically designed to alleviate inflammation and manage pain symptoms experienced by individuals suffering from osteoarthritis and multiple sclerosis. Established in 2020, APUS has its corporate headquarters situated in Hopewell, New Jersey, and operates as a subsidiary of Api Meds, Inc.
Aktiekurs
$4.70
Senast synkroniserad: 2026-08-14
Marknadsvärde
$7.09M
Förändring (1 dag)
-0.21%
Förändring (1 år)
-70.63%
Land
US
Handel Apimeds Pharmaceuticals US, Inc (APUS)

Kategori

Aktiekurshistorik för Apimeds Pharmaceuticals US, Inc (APUS)
Högsta slutkurs: $4.53 den 2026-08-01

Lägsta slutkurs: $18.03 den 2025-05-01
Aktiekurshistorik för Apimeds Pharmaceuticals US, Inc från 2025 till 2026
Årlig aktiekursutveckling
År Prestanda
2026 (TTM) -15.19%
2025 0.00%
Aktiekurs för liknande företag eller konkurrenter
Företag Aktiekurs Förändring 1år% Land
$505.24 28.63%
US
$846.09 29.41%
NL
$731.95 6.51%
CH
$1.07K -6.40%
KR
$254.79 13.07%
BE